ARTICLE | Clinical News
FDA accepts NDA for Kitov's KIT-302 to treat OA pain and hypertension
November 30, 2017 11:20 PM UTC
FDA accepted for review an NDA from Kitov Pharmaceuticals Holdings Ltd. (Tel Aviv:KTOV; NASDAQ:KTOV) for celecoxib/amlodipine besylate (KIT-302) to treat pain associated with osteoarthritis and hypertension simultaneously. The PDUFA date is May 31...
BCIQ Company Profiles